The Crossroads between Osteosarcopenia and Intrinsic Capacity – A Narrative Review.

👤 Authors: Nailton José Neto, Guy Hajj-Boutros, Wayne Lok, Miguel G Borda, Konstantinos Prokopidis, Hassan Rammal, Daniel Rivas, Hussein Samhat, Ivan Baltasar-Fernandez, Mahdi Imani, Cristiano Dos Santos Gomes, Oscar Rosas Carrasco, Marc Sim, Julie A Pasco, Julia Chabot, Ana Maria Ayala-Copete, Francisco José García-García, Claire Godard-Sebillotte, Raman Agnihotram, Lana Williams, Anna Andrianova, Robinson Ramirez-Vélez, Emma Connolly, Harmehr Sekhon, Hidenori Arai, Liang-Kung Chen, Andréa Faust, Howard Bergman, Alexandra Papaioannou, Pierrette Gaudreau, Tiago Da Silva Alexandre, Leocadio Rodriguez-Mañas, Ricardo Oliveira Guerra, Gustavo Duque

ABSTRACT:

Intrinsic Capacity (IC) is defined as the composite of physical and mental abilities an individual possesses, encompassing five domains: cognition, psychological health, sensory function, vitality, and locomotion. This construct is central to the World Health Organization's framework for assessing functional ability in older adults.

Growing evidence highlights the critical role of the musculoskeletal system in maintaining these domains, while conditions such as sarcopenia, osteoporosis, and their coexistence as osteosarcopenia (OS) are increasingly associated with IC decline. This narrative review compiles current evidence on the modulatory role of muscles and bones in IC and the impacts of sarcopenia, osteoporosis, and OS.

Most findings suggest that musculoskeletal tissues influence IC not only through biomechanical functions but also as secretory organs, releasing myokines and osteokines with endocrine, paracrine, and autocrine effects. Among the most studied are brain-derived neurotrophic factor, irisin, osteocalcin, and interleukin-6.

Dysregulation of these pathways, along with biomechanical dysfunction and systemic inflammation, links sarcopenia, osteoporosis, and OS to IC impairment. Further research is needed to clarify the specific mechanisms involved, particularly in the sensory and vitality domains, to inform targeted interventions that promote healthy aging.

Hidenori Arai

Geriatrics

National Center for Geriatrics and Gerontology

Japan

2103

ScienceLeadR Reputation
profile photo of Hidenori Arai

Main topics

Publications Clinical Trials

Sarcopenia
Dyslipidemias
Cognitive Dysfunction
Cognition Disorders
Lipid Metabolism Disorders
View detailed profile

Miguel German Borda

Geriatrics

Stavanger University Hospital

Norway

376

ScienceLeadR Reputation
profile photo of Miguel German Borda

Main topics

Publications Clinical Trials

Sarcopenia
Dementia
Neurocognitive Disorders
Cognitive Dysfunction
Cognition Disorders
View detailed profile

Subscribe to the SCWD Newsletter

Stay Informed with the Latest Updates and Exclusive Insights!